Brazilian HTA To Adopt Cost-Effectiveness Thresholds
Executive Summary
Brazil’s health technology assessment institute is to incorporate cost-effectiveness thresholds into its decision making.
You may also be interested in...
Mexico Continues Reliance Strategy To Expand Drug Access
Mexico aims to speed up the registration of generics and biosimilars.
Belgium Aims To Drive Biologic Competition Through Tendering
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.
Companies Need EU Funding To Cover ‘Enormous Expenditure’ Of Complying With Revised GMP Rules
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.